Pulmonary Fibrosis
The DOI matches its Crossref record, with a small difference in title or year; 37 of the 38 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Substantial challenges remain in our understanding of fibrotic lung diseases. Nowhere is this more true than in the elucidation and verification of the pathogenetic basis upon which they develop. Scientific progress, most recently in the field of experimental therapy, has relied closely on interpreting data derived from animal modeling. Such models are used to identify the cellular interactions and molecular pathways involved in lung tissue repair and fibrosis. Over the coming years, the significance of new discoveries will continue to be evaluated using the in vivo analysis of animal models substituting for patients with actual pulmonary fibrosis. The commonest strategy to induce experimental pulmonary fibrosis is by directly administering a profibrotic agent to either wild-type animals or those that bear a specific genetic modification. The creation of new models has been greatly enhanced by the availability of stem cell lines and methods for introducing genetic mutations into these cells. Despite an increasing choice of models, there are still good reasons to continue adapting and using one of its earliest examples, the bleomycin model, in post-genomic pulmonary fibrosis research. A brief review of the exacting requirements of such research will place the strengths of this particular model in perspective.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pulmonary fibrosis is also included in the host response to reverse the loss of essential metal after its sequestration by asbestos (Figure 3 and Figure 4) [64].”
From Asbestos and Iron (2023) · cites this paper as [64]
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification
KATZENSTEIN, A.-L. A., & MYERS, J. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.4.9707039 · Cited by 1,261
Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis
Phillips, R. J., Burdick, M. D., Hong, K., Lutz, M. A., Murray, L. A., Xue, Y. Y., Belperio, J. A., Keane, M. P., & Strieter, R. M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420997 · Cited by 1,079
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Self-citationLee, C. G., Homer, R. J., Zhu, Z., Lanone, S., Wang, X., Koteliansky, V., Shipley, J. M., Gotwals, P., Noble, P., Chen, Q., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.809 · Cited by 940
Resolution of Lung Inflammation by CD44
Teder, P., Vandivier, R. W., Jiang, D., Liang, J., Cohn, L., Puré, E., Henson, P. M., & Noble, P. W. (2002) · Science · doi:10.1126/science.1069659 · Cited by 677
Selman, M., Ruiz, V., Cabrera, S., Segura, L., Ramírez, R., Barrios, R., & Pardo, A. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.279.3.l562 · Cited by 425
Kaminski, N., Allard, J. D., Pittet, J. F., Zuo, F., Griffiths, M. J. D., Morris, D., Huang, X., Sheppard, D., & Heller, R. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1778 · Cited by 417
Giri, S. N., Hyde, D. M., & Hollinger, M. A. (1993) · Thorax · doi:10.1136/thx.48.10.959 · Cited by 402
Research works printed but not linked: 5
- 1993, Monogr Pathol, 36, 78
- 2002, Respir Res, 3, 1
- 1978, Am Rev Respir Dis, 117, 289
- 1996, Lab Invest, 74, 12
- 1993, Thorax, 48, 956
Cited by
Items 101–200 of 316
Wang, Y., Ding, L., Li, Z., Chen, G., Sun, M., & Oupický, D. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.10.030 · Cited by 49
Rønnow, S. R., Dabbagh, R. Q., Genovese, F., Nanthakumar, C. B., Barrett, V. J., Good, R. B., Brockbank, S., Cruwys, S., Jessen, H., Sorensen, G. L., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01369-1 · Cited by 45
Pulmonary delivery of docosahexaenoic acid mitigates bleomycin-induced pulmonary fibrosis
Zhao, H., Chan‐Li, Y., Collins, S. L., Zhang, Y., Hallowell, R. W., Mitzner, W., & Horton, M. R. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-64 · Cited by 51
Egger, C., Gérard, C., Vidotto, N., Accart, N., Cannet, C., Dunbar, A., Tigani, B., Piaia, A., Járai, G., Jarman, E., et al. (2014) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00027.2014 · Cited by 49
Urushiyama, H., Terasaki, Y., Nagasaka, S., Terasaki, M., Kunugi, S., Nagase, T., Fukuda, Y., & Shimizu, A. (2015) · Laboratory Investigation · doi:10.1038/labinvest.2015.66 · Cited by 46
Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades
Wirsdörfer, F., & Jendrossek, V. (2017) · Radiation Oncology · doi:10.1186/s13014-017-0865-1 · Cited by 47
Sung, D. K., Kong, W. H., Park, K., Kim, J. H., Kim, M. Y., Kim, H., & Hahn, S. K. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.061 · Cited by 43
Animal models of pulmonary fibrosis: how far from effective reality?
Gauldie, J., & Kolb, M. R. J. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00520.2007 · Cited by 50
Self-citationMoeller, A., Rodriguez-Lecompte, J. C., Wang, L., Gauldie, J., & Kolb, M. R. J. (2006) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2006.09.006 · Cited by 50
Self-citationHartopo, A. B., Emoto, N., Vignon‐Zellweger, N., Suzuki, Y., Yagi, K., Nakayama, K., & Hirata, K. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0354oc · Cited by 42
He, M., Cheng, N., Gao, W.-W., Zhang, M., Zhang, Y.-Y., Ye, R. D., & Wang, M.-W. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.4 · Cited by 42
S-allyl cysteine attenuated CCl4-induced oxidative stress and pulmonary fibrosis in rats
Mizuguchi, S., Takemura, S., Minamiyama, Y., Kodai, S., Tsukioka, T., Inoue, K., Okada, S., & Suehiro, S. (2006) · BioFactors · doi:10.1002/biof.5520260108 · Cited by 42
Babin, A. L., Cannet, C., Gérard, C., Wyss, D., Page, C. P., & Beckmann, N. (2011) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.22476 · Cited by 45
Pulmonary Antifibrotic Mechanisms Aspirin-Triggered Lipoxin A4 Synthetic Analog
Guilherme, R. F., Xisto, D. G., Kunkel, S. L., Freire-de-Lima, C. G., Rocco, P. R. M., Neves, J. S., Fierro, I. M., Canetti, C. D. A., & Benjamim, C. F. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0462oc · Cited by 43
MyD88 provides a protective role in long-term radiation-induced lung injury
Brickey, W. J., Neuringer, I. P., Walton, W. G., Hua, X., Wang, E. Y., Jha, S., Sempowski, G. D., Yang, X., Kirby, S. L., Tilley, S. L., et al. (2012) · International Journal of Radiation Biology · doi:10.3109/09553002.2012.652723 · Cited by 41
Zhang, H., Liu, X., Chen, S., Wu, J., Ye, X., Xu, L., Chen, H., Zhang, D., Tan, R. X., & Wang, Y. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.06.022 · Cited by 40
Tülek, B., Kıyan, E., Toy, H., Kıyıcı, A., Narin, C., & Süerdem, M. (2011) · Clinical and investigative medicine · doi:10.25011/cim.v34i6.15894 · Cited by 42
Zheng, M., Liu, K., Li, L., Feng, C., & Wu, G. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02251-0 · Cited by 40
Lung regeneration: diverse cell types and the therapeutic potential
Chen, Y., Li, Z., Ji, G., Wang, S., Mo, C., & Ding, B. (2024) · MedComm · doi:10.1002/mco2.494 · Cited by 39
Shapiro, S. D. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2609001 · Cited by 45
Smoking-related Small Airway Disease—A Review and Update
Beasley, M. B. (2010) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181e3bf97 · Cited by 38
Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis
Saleh, M., Kiaei, S. Z. F., & Kavianpour, M. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02746-x · Cited by 39
Hagiwara, S., Iwasaka, H., Matsumoto, S., Noguchi, T., & Yoshioka, H. (2007) · Lung · doi:10.1007/s00408-007-9018-x · Cited by 38
Grabarz, F., de Aguiar, C. F., Corrêa-Costa, M., Braga, T. T., Hiyane, M. I., Andrade‐Oliveira, V., Landgraf, M. A., & Câmara, N. O. S. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0383-7 · Cited by 37
Soluble ECM promotes organotypic formation in lung alveolar model
Valdoz, J. C., Franks, N. A., Cribbs, C. G., Jacobs, D. J., Dodson, E. L., Knight, C. J., Poulson, P. D., Garfield, S. R., Johnson, B. C., Hemeyer, B. M., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121464 · Cited by 37
Bleomycin‐induced lung injury in mice investigated by MRI: Model assessment for target analysis
Babin, A. L., Cannet, C., Gérard, C., Saint-Mézard, P., Page, C. P., Sparrer, H., Matsuguchi, T., & Beckmann, N. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23009 · Cited by 37
Lynch, J. P., Fishbein, M. C., Saggar, R., Zisman, D. A., & Belperio, J. A. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.3.377 · Cited by 37
Organ, L. A., Bacci, B., Koumoundouros, E., Barcham, G., Milne, M., Kimpton, W. G., Samuel, C. S., & Snibson, K. J. (2015) · BMC Pulmonary Medicine · doi:10.1186/s12890-015-0071-6 · Cited by 38
Dekoster, K., Decaesteker, T., Berghen, N., Broucke, S. V. D., Jonckheere, A., Wouters, J., Krouglov, A., Lories, R. J. U., Langhe, E. D., Hoet, P., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-73056-6 · Cited by 38
Hesse, C., Beneke, V., Konzok, S., Diefenbach, C., Sand, J. M. B., Rønnow, S. R., Karsdal, M. A., Jonigk, D. D., Sewald, K., Braun, A. C., et al. (2022) · Respiratory Research · doi:10.1186/s12931-022-02116-4 · Cited by 35
Chronic Pleuropulmonary Fibrosis and Elastosis of Aged Donkeys
Miele, A., Dhaliwal, K., du Toit, N., Murchison, J. T., Dhaliwal, C. A., Brooks, H. W., Smith, S. H., Hirani, N., Schwarz, T., Haslett, C., et al. (2014) · CHEST Journal · doi:10.1378/chest.13-1306 · Cited by 35
A microfluidic lung‐on‐a‐chip based on biomimetic hydrogel membrane
Shen, C., Yang, H., She, W., & Meng, Q. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28426 · Cited by 34
Deficiency of α7 Nicotinic Acetylcholine Receptor Attenuates Bleomycin-Induced Lung Fibrosis in Mice
Sun, P., Li, L., Zhao, C., Pan, M., Qian, Z., & Su, X. (2017) · Molecular Medicine · doi:10.2119/molmed.2016.00083 · Cited by 36
Liu, Y., Liu, B., Zhang, G., Zou, J., Zou, M., & Cheng, Z. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1499-z · Cited by 33
Insights on the mechanism of bleomycin to induce lung injury and associated in vivo models: A review
Ayilya, B. L., Balde, A., Ramya, M., Benjakul, S., Kim, S., & Nazeer, R. A. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110493 · Cited by 37
Marquis, J.-F., Nantel, A., LaCourse, R., Ryan, L., North, R. J., & Gros, P. (2007) · Infection and Immunity · doi:10.1128/iai.00369-07 · Cited by 33
Failla, M., Genovese, T., Mazzon, E., Fruciano, M., Fagone, E., Gili, E., Barera, A., Rosa, C. L., Conte, E., Crimi, N., et al. (2008) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2007-0438oc · Cited by 33
In perspective: Murine models of scleroderma
Wu, M., & Varga, J. (2008) · Current Rheumatology Reports · doi:10.1007/s11926-008-0030-9 · Cited by 34
Wang, Y., Jing, W., Qu, W., Liu, Z., Zhang, D., Qi, X., & Liu, L. (2020) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13271 · Cited by 30
Lymphatics in Idiopathic Pulmonary Fibrosis: New Insights into an Old Disease
El‐Chemaly, S., Pacheco–Rodriguez, G., Ikeda, Y., Malide, D. A., & Moss, J. (2009) · Lymphatic Research and Biology · doi:10.1089/lrb.2009.0014 · Cited by 31
Investigational approaches to therapies for idiopathic pulmonary fibrosis
Gomer, R. H., & Lupher, M. L. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.484018 · Cited by 29
Zhang, H., Lawson, W. E., Polosukhin, V. V., Pozzi, A., Blackwell, T. S., Litingtung, Y., & Chiang, C. C. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070226 · Cited by 30
Robbe, A., Tassin, A., Carpentier, J., Declèves, A., Ngono, Z. L. M., Nonclercq, D., & Legrand, A. (2015) · BioMed Research International · doi:10.1155/2015/198418 · Cited by 29
Kim, C., Jeong, S. H., Kim, J., Lee, K. Y., Cha, J., Lee, C. H., Park, E., & Lee, J. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-85662-z · Cited by 29
Richeldi, L., Collard, H. R., du Bois, R. M., Jenkins, G. R., Kolb, M. R. J., Maher, T. M., Raghu, G., Vancheri, C., & Laurent, G. J. (2013) · European Respiratory Journal · doi:10.1183/09031936.00038613 · Cited by 29
Self-citationXu, X., Dai, H., & Wang, C. (2014) · The Clinical Respiratory Journal · doi:10.1111/crj.12190 · Cited by 32
Hunninghake, G. W., & Schwarz, M. I. (2007) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200702-036ms · Cited by 31
Brazee, P. L., Allen, N., Knipe, R. S., Redente, E. F., & Saux, C. J. L. (2025) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/a-2649-9402 · Cited by 27
Park, J., Jang, J., Cha, S.-R., Baek, H., Lee, J., Hong, S., Lee, H., Lee, T., & Yang, S. (2022) · Antioxidants · doi:10.3390/antiox11122462 · Cited by 30
The CD73/Ado System—A New Player in RT Induced Adverse Late Effects
de Leve, S., Wirsdörfer, F., & Jendrossek, V. (2019) · Cancers · doi:10.3390/cancers11101578 · Cited by 28
Lee, S. Y., Park, S., Lee, S., Kim, H., Kwon, J.-H., Yoo, J., Kim, K., Park, M. S., Lee, C. G., Elias, J. A., et al. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01066-1 · Cited by 26
Williamson, J. D., Sadofsky, L. R., Crooks, M. G., Greenman, J., & Hart, S. P. (2016) · Experimental Lung Research · doi:10.1080/01902148.2016.1243742 · Cited by 25
Cell Therapy in Idiopathic Pulmonary Fibrosis†
Serrano‐Mollar, A. (2018) · Medical Sciences · doi:10.3390/medsci6030064 · Cited by 27
A Chinese Traditional Therapy for Bleomycin-Induced Pulmonary Fibrosis in Mice
Sun, L., Mao, M., Yan, Z., Zuo, C., & Zhang, X. (2018) · Canadian Respiratory Journal · doi:10.1155/2018/8491487 · Cited by 26
Cai, Z., Tian, Y., Li, J.-Z., Zhao, P., Li, J., Mei, X., & Bai, Y. (2022) · Bioscience Reports · doi:10.1042/bsr20220986 · Cited by 25
Pulmonary Vaccination as a Novel Treatment for Lung Fibrosis
Collins, S. L., Chan‐Li, Y., Hallowell, R. W., Powell, J. D., & Horton, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031299 · Cited by 28
Rolipram attenuates bleomycin A5‐induced pulmonary fibrosis in rats
Jin Bing, P. A. N., Yu Hong, H. O. U., & ZHANG, G. J. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01606.x · Cited by 25
A rat model of oral submucous fibrosis induced by bleomycin
Zhang, S., Gong, Z., Xiong, W., Wang, X., Min, Q., Luo, C., & Ling, T.-Y. (2016) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2015.07.042 · Cited by 25
Radiation-Induced Impairment in Lung Lymphatic Vasculature
Cui, Y., Wilder, J. A., Rietz, C., Gigliotti, A. P., Tang, X., Shi, Y., Guilmette, R. A., Wang, H., George, G., de Magaldi, E. N., et al. (2014) · Lymphatic Research and Biology · doi:10.1089/lrb.2014.0012 · Cited by 24
Update in Diffuse Parenchymal Lung Disease 2006
Wells, A. U., & Hogaboam, C. M. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-052up · Cited by 25
BARD1 mediates TGF-β signaling in pulmonary fibrosis
André, P., Prêle, C. M., Vierkotten, S., Carnésecchi, S., Donati, Y. R. A., Chambers, R. C., Pache, J., Crestani, B., Barazzone‐Argiroffo, C., Königshoff, M., et al. (2015) · Respiratory Research · doi:10.1186/s12931-015-0278-3 · Cited by 25
Self-citationYan, Q., Quan, Y., Sun, H., Peng, X., Zou, Z., Alcorn, J. L., Wetsel, R. A., & Wang, D. (2013) · Stem Cells · doi:10.1002/stem.1570 · Cited by 27
Treatment with chondroitinase ABC alleviates bleomycin-induced pulmonary fibrosis
Kai, Y., Yoneyama, H., Koyama, J., Hamada, K., Kimura, H., & Matsushima, K. (2007) · Medical Molecular Morphology · doi:10.1007/s00795-007-0370-y · Cited by 24
Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
Arora, A., Bhuria, V., Hazari, P. P., Pathak, U., Mathur, S., Roy, B. G., Sandhir, R., Soni, R., Dwarakanath, B. S. R., & Bhatt, A. N. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00394 · Cited by 23
How useful is traditional herbal medicine for pulmonary fibrosis?
Yang, J., Cui, Y., & Kolb, M. R. J. (2009) · Respirology · doi:10.1111/j.1440-1843.2009.01644.x · Cited by 23
Relationships between Early Inflammatory Response to Bleomycin and Sensitivity to Lung Fibrosis
Pottier, N., Chupin, C., Defamie, V., Cardinaud, B., Sutherland, R., Rios, G., Gauthier, F., Wolters, P. J., Berthiaume, Y., Barbry, P., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200607-1051oc · Cited by 23
Zhou, X., Zhao, Y., He, C., & Li, J.-X. (2012) · Journal of Chinese Integrative Medicine · doi:10.3736/jcim20120211 · Cited by 22
Skurikhin, Е. G., Pershina, О. V., Reztsova, A. M., Ermakova, N. N., Khmelevskaya, E. S., Krupin, V. A., Stepanova, I. E., Artamonov, A. V., Bekarev, A. A., Мадонов, П. Г., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125065 · Cited by 22
Pathogenesis of systemic sclerosis
Varga, J., & Lafyatis, R. (2011) · Elsevier eBooks · doi:10.1016/b978-0-323-06551-1.00139-1 · Cited by 24
Lack of evidence for caveolin-1 and CD147 interaction before and after bleomycin-induced lung injury
Barth, K., Bläsche, R., & Kasper, M. E. (2006) · Histochemistry and Cell Biology · doi:10.1007/s00418-006-0192-3 · Cited by 22
Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice
Chilakapati, S. R., Serasanambati, M., Manikonda, P. K., Chilakapati, D. R., & WATSON, R. R. (2014) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2014-0006 · Cited by 46
Attenuation of Bleomycin-Induced Pulmonary Fibrosis in Rats with S-Allyl Cysteine
Tsukioka, T., Takemura, S., Minamiyama, Y., Mizuguchi, S., Toda, M., & Okada, S. (2017) · Molecules · doi:10.3390/molecules22040543 · Cited by 21
Grandi, A., Ferrini, E., Mecozzi, L., Ciccimarra, R., Zoboli, M., Leo, L., Khalajzeyqami, Z., KleinJan, A., Löwik, C. W. G. M., Donofrío, G., et al. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00180.2022 · Cited by 20
Cui, K., Kou, J., Gu, J., Han, R., Wang, G., Zhen, X., & Qin, Z. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-461 · Cited by 21
Cigarette Smoke Particle-Induced Lung Injury and Iron Homeostasis
Ghio, A. J., Pavlisko, E. N., Roggli, V. L., Todd, N. W., & Sangani, R. G. (2022) · International Journal of Chronic Obstructive Pulmonary Disease · doi:10.2147/copd.s337354 · Cited by 19
The Pulmonary Toxicity of Anticancer Agents
Yoneda, K. Y., & Cross, C. E. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00924-6 · Cited by 25
An agent-based modeling approach for lung fibrosis in response to COVID-19
Islam, M. A., Getz, M., Macklin, P., & Versypt, A. N. F. (2023) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011741 · Cited by 20
Yoshida, T., Ohnuma, A., Horiuchi, H., & Harada, T. (2011) · Journal of Toxicologic Pathology · doi:10.1293/tox.24.9 · Cited by 21
Draining the Pleural Space: Lymphatic Vessels Facing the Most Challenging Task
Solari, E., Marcozzi, C., Ottaviani, C., Negrini, D., & Moriondo, A. (2022) · Biology · doi:10.3390/biology11030419 · Cited by 21
Gien, J., Tseng, N., Seedorf, G., Kuhn, K., & Abman, S. H. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00066.2016 · Cited by 18
Updates on animal models of systemic sclerosis
Soare, A., Ramming, A., Avouac, J., & Distler, J. H. W. (2016) · Journal of Scleroderma and Related Disorders · doi:10.5301/jsrd.5000220 · Cited by 21
Jing, F., Chen, X., Xue, J., Huang, K., Xing, F., Hu, X., Peng, Y., & Liu, C. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.805432 · Cited by 19
Modelos experimentales para el estudio de la fibrosis pulmonar: utilidad práctica actual y futura
Molina‐Molina, M., Pereda, J., & Xaubet, A. (2007) · Archivos de Bronconeumología · doi:10.1157/13109471 · Cited by 18
Pinart, M., Serrano‐Mollar, A., Llatjós, R., Rocco, P. R. M., & Romero, P. V. (2009) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2009.01.002 · Cited by 18
Yin, Q., Brody, A. R., & Sullivan, D. E. (2007) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2007.00545.x · Cited by 19
Nakamura, T., Hoshino, Y., Yamada, A., Teratani, A., Furukawa, S., Okuyama, H., Ueda, S., Wada, H., Yodoi, J., & Nakamura, H. (2007) · Free Radical Research · doi:10.1080/10715760701487682 · Cited by 18
Experimental Models for the Study of Pulmonary Fibrosis: Current Usefulness and Future Promise
Molina‐Molina, M., Pereda, J., & Xaubet, A. (2007) · Archivos de Bronconeumología · doi:10.1016/s1579-2129(07)60115-3 · Cited by 21
Yang, C.-G., Mao, X., Wu, J.-F., An, X., Cao, J., Zhang, X., Li, M., & Zhang, F.-F. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500192 · Cited by 17
Leukocyte navigation mechanisms as targets in airway diseases
Medina‐Tato, D. A., Watson, M., & Ward, S. G. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.08.008 · Cited by 18
Keshavan, S., Bannuscher, A., Drašler, B., Barošová, H., Petri‐Fink, A., & Rothen‐Rutishauser, B. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106387 · Cited by 16
Exercise attenuates pulmonary injury in mice with bleomycin-induced pulmonary fibrosis
Prata, L. O., Oliveira, F. M. S., Ribeiro, T. M. S., Almeida, P., Cardoso, J. A., Rodrigues‐Machado, M. D. G., & Caliari, M. V. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.011334 · Cited by 17
Ghio, A. J., Stewart, M., Sangani, R. G., Pavlisko, E. N., & Roggli, V. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512390 · Cited by 15
“Pulmonary fibrosis is also included in the host response to reverse the loss of essential metal after its sequestration by asbestos (Figures 3 and 4) [64].”
BackgroundDetrimental pro-senescence effects of vitamin D on lung fibrosis
Guijarro, T., Magro-López, E., Manso, J., Martínez, R. G., Fernández‐Aceñero, M. J., Liste, I., & Zambrano, A. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0064-z · Cited by 16
SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib
Ravanetti, F., Ferrini, E., Ragionieri, L., Khalajzeyqami, Z., Nicastro, M., Ridwan, Y. R., KleinJan, A., Villetti, G., Grandi, A., & Stellari, F. F. (2021) · Scientific Reports · doi:10.1038/s41598-021-97728-z · Cited by 15
Imbalance of Receptor-Regulated and Inhibitory Smads in Lung Fibroblasts from Bleomycin-Exposed Rats
Gonzalez, A. V., Bellego, F. L., & Ludwig, M. S. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0132oc · Cited by 15
Basta, M. D., Petruk, S., Summer, R., Rosenbloom, J., Wermuth, P. J., Macarak, E., Levin, A. V., Mazo, A., & Walker, J. L. (2023) · iScience · doi:10.1016/j.isci.2023.106570 · Cited by 14
Magnetic Resonance Elastography (MRE) of Bleomycin-Induced Pulmonary Fibrosis in an Animal Model
Fakhouri, F. S., Joseph, M., Ballinger, M. N., Shukla, V. C., Weimar, D., Novak, C. M., Ghadiali, S. N., & Kolipaka, A. (2022) · Investigative Radiology · doi:10.1097/rli.0000000000000935 · Cited by 14
Wu, Q., Zhou, Y., Feng, F., Jin, Y., Wang, Z., & Zhou, X. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/9658950 · Cited by 14
Efficacies of rosiglitazone and retinoin on bleomycin-induced pulmonary fibrosis in rats
Yu, W., Mi, L., & Long, T. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4555 · Cited by 13
Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice
Barravecchia, I., Lee, J. M., Manassa, J., Magnuson, B., Ferris, S. F., Cavanaugh, S., Steele, N. G., Espinoza, C. E., Galbán, C. J., Ramnath, N., et al. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0480 · Cited by 13
Metadata
- Authors
- Chua, F., Gauldie, J., & Laurent, G. J.
- Affiliations
- The Royal Free Hospital (GB)
- ORCID
- Chua, Felix
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-07-01
- Volume
- 33
- Issue
- 1
- Pages
- 9-13
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2051772841
- Cited by
- 305
- References
- 36
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 10 · 2023: 24 · 2022: 18 · 2021: 7 · 2020: 12 · 2019: 7 · 2018: 13 · 2017: 17 · 2016: 7 · 2015: 12 · 2014: 19 · 2013: 19 · 2012: 12
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory Cell and Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary fibrosis, bleomycin-induced fibrosis, experimental fibrosis, genetic modification, stem cell lines, lung repair, fibrosis pathogenesis, postgenomics
- MeSH terms
- Animals, Antimetabolites, Antineoplastic, Bleomycin, Disease Models, Animal, Extracellular Matrix, Fibrosis, Humans, Lung, Lung Diseases, Models, Biological, Mutation, Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.